Tongshen Bio-Health's revenue in the third quarter of 2025 increased by 23.45% year-on-year, accelerating the iteration of new products and the expansion of product categories

2025-10-30 11:21 0

/PRZWT/On the evening of October 29th, Tongshen Bio-Health released its third-quarter report for 2025. The report shows that in the third quarter, Tongshen Bio-Health achieved operating revenue of 1.383 billion yuan and net profit attributable to shareholders of the listed company of 170 million yuan. Both revenue and profit increased year-on-year in the third quarter. The cumulative revenue for the first three quarters was 4.915 billion yuan, and the net profit attributable to the parent company was 907 million yuan. After the year-on-year growth rate of net profit in the second quarter turned positive, the profit in the third quarter increased by 861.91% year-on-year. Moreover, the profit in the first three quarters resumed year-on-year growth, and the operating capacity improved quarter by quarter, accumulating key momentum for subsequent development.

Since 2025, Tongshen Bio-Health has taken product innovation as the core breakthrough point. By accelerating the iteration of new products and the expansion of product categories, it has continuously optimized its product matrix. In the first three quarters, it has cumulatively launched 71 brand-new single products. In terms of product strategy, Tongshen Bio-Health has established a dual-track layout of "upgrading basic nutrients" and "breaking through in professional functional categories", which not only consolifies its foundation in the mass consumer market but also continuously breaks through in professional fields.

In the field of basic nutrients with a wide market demand and high repurchase rates, Tongshen Bio-Health has been promoting product upgrades around the principle of "high quality-to-price ratio", effectively driving category growth and expanding the user base. In addition to iterating and upgrading its existing functional products, Tongshen Bio-Health is also actively extending into high-professional-barrier heavy-functional categories.

In the face of channel transformation, Tongshen Bio-Health has implemented a differentiated inventory strategy based on different consumption scenarios and population characteristics both online and offline, focusing on optimizing the channel value chain. The adjustment results are gradually emerging. In terms of offline operations, Tongshen Bio-Health continuously launches high-quality and cost-effective new products and empowers distributors, meticulously cultivating and promoting the improvement of channel operation quality. In terms of online operations, Tongshen Bio-Health is upgrading towards "specialization, segmentation and high-endization", optimizing supply in line with user demands. Data from e-commerce platforms show that in the first three quarters, new e-commerce exclusive products such as Tongshen Bio-Health's multi-dimensional double-layer tablets and adult calcium series performed outstandingly, driving up the market share of related categories.

Under the guidance of the "Scientific Nutrition" strategy, the company continued to promote the research and development and transformation of new raw materials, new functions and new technologies in the third quarter. As of September 30, 2025, Tongshen Bio-Health has cumulatively obtained 487 domestic and foreign patents, and its technological reserves and product compliance capabilities are both among the top in the industry. In addition, after becoming a partner of China's Antarctic scientific research life exploration (Subglacial lake) in May, Tongshen Bio-Health once again officially announced in September that it has become the exclusive bone nutrition partner of the Mount Everest climbing exploration, further enhancing the brand's professional image.

After experiencing a sharp decline in 2024, Tongshen Bio-Health made systematic adjustments in multiple dimensions such as products, channels, R&D, and brand, achieving reform results in a short period of time and demonstrating the operational resilience of a leading enterprise. In the future, with the continuous release of new product increments and the improvement of operational efficiency, the company is expected to stabilize and recover after a rapid adjustment, laying a solid foundation for long-term development.

Source: Corporate press release
Press release Overseas media release advertorials Release advertorials release press conference Release press release overseas media release media release platform media release release press release Invite media to invite overseas press release Overseas press release